N-(1-DEOXY-2,3:4,5-DI-O-ISOPROPYLIDENE-BETA-D-FRUCTOPYRANOS-1-YL)-N-METHYL-L-TYROSYLGLYCYLGLYCYL-L-PHENYLALANYL-L-LEUCINE;P-MEYGGFL
Compound with spectra: 1 NMR
| SpectraBase Compound ID | F6ZyAUNIpkZ |
|---|---|
| InChI | InChI=1S/C41H57N5O12/c1-24(2)17-29(38(52)53)45-36(50)28(18-25-11-9-8-10-12-25)44-33(49)21-42-32(48)20-43-37(51)30(19-26-13-15-27(47)16-14-26)46(7)23-41-35(57-40(5,6)58-41)34-31(22-54-41)55-39(3,4)56-34/h8-16,24,28-31,34-35,47H,17-23H2,1-7H3,(H,42,48)(H,43,51)(H,44,49)(H,45,50)(H,52,53)/t28?,29?,30?,31-,34-,35+,41+/m1/s1 |
| InChIKey | HJZDXRSYUZIMKS-NPKJDYKTSA-N |
| Mol Weight | 811.9 g/mol |
| Molecular Formula | C41H57N5O12 |
| Exact Mass | 811.400372 g/mol |
| Enantiomer InChIKey | HJZDXRSYUZIMKS-AHKYGCABSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD3OD |
acetamide, N-acetyl-N-(hexahydro-7,7,8a-trimethyl-2-oxo-3-(phenylmethyl)-5-thioxoimidazo[1,2-c]pyrimidin-1(5H)-yl)-
3-AZIDOPROPYL-BETA-D-GALACTOPYRANOSYL-(1->4)-BETA-L-RHAMNOPYRANOSYL-(1->4)-BETA-D-GLUCOPYRANOSYL-(1->4)-[5-ACETAMIDO-3,5-DIDEOXY-D-GLYCERO
IGZMLVNDIYBLPA-UGHIDPIKSA-N
YSHABHNOVDIDCX-XPAKHABFSA-N
IGZMLVNDIYBLPA-UQAVCFTQSA-N
13-HYDROXY-3-DEHYDROXY-3,12-OXA-DESMYCOSIN-20-DIMETHYL-ACETAL
(1R,2R,4R,5R,7R,8R,9R)-N-(11-AZIDO-4,5-DIMETHOXY-4,5-DIMETHYL-3,6,13-TRIOXA-10-AZATRICYCLO-[7.3.1.0(2,7)]-TRIDEC-10-EN-8-YL)-ACETAMIDE
Virginiamycin S1
KAEMPFEROL-3-O-ALPHA-L-(2'',4''-DI-E-FERULOYL)-RHAMNOPYRANOSIDE
TRILOBATIN-A
| Title | Journal or Book | Year |
|---|---|---|
| CD and FTIR spectroscopic studies of Amadori compounds related to the opioid peptides | Journal of the Chemical Society, Perkin Transactions 2 | 1997 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.